Categories AlphaGraphs, Earnings, Health Care
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also provided guidance for fiscal 2023.
September-quarter earnings, adjusted for special items, moved up to $4.08 per share from $4.01 per share in the same period of 2022. Unadjusted profit was $1.04 billion or $3.97 per share, vs. $930.5 million or $3.59 per share a year earlier.
The company said that third-quarter revenues increased to $2.48 billion from $2.33 billion in the year-ago period. For the whole of fiscal 2023, the management expects total product revenues to be in the range of $9.85 billion.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Microsoft expected to report higher Q3 revenue, profit
Tech behemoth Microsoft Corp. (NASDAQ: MSFT) is preparing to report its third-quarter 2025 results, amid expectations for a year-over-year increase in revenue and earnings. The company has performed well recently,
What to expect when eBay (EBAY) reports its Q1 2025 earnings results
Shares of eBay Inc. (NASDAQ: EBAY) were down slightly in midday trade on Friday. The stock has gained 8% year-to-date. The ecommerce giant is slated to report its earnings results
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
